Gabriella Ferrandina

21.9k total citations · 2 hit papers
496 papers, 15.8k citations indexed

About

Gabriella Ferrandina is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology. According to data from OpenAlex, Gabriella Ferrandina has authored 496 papers receiving a total of 15.8k indexed citations (citations by other indexed papers that have themselves been cited), including 225 papers in Reproductive Medicine, 216 papers in Obstetrics and Gynecology and 148 papers in Oncology. Recurrent topics in Gabriella Ferrandina's work include Endometrial and Cervical Cancer Treatments (202 papers), Ovarian cancer diagnosis and treatment (198 papers) and Endometriosis Research and Treatment (66 papers). Gabriella Ferrandina is often cited by papers focused on Endometrial and Cervical Cancer Treatments (202 papers), Ovarian cancer diagnosis and treatment (198 papers) and Endometriosis Research and Treatment (66 papers). Gabriella Ferrandina collaborates with scholars based in Italy, United States and Japan. Gabriella Ferrandina's co-authors include Giovanni Scambia, Anna Fagotti, Francesco Fanfani, Stefano Mancuso, Gian Franco Zannoni, Franco O. Ranelletti, Valerio Gallotta, Enrica Martinelli, Francesco Legge and Marco Petrillo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Gabriella Ferrandina

480 papers receiving 15.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas

1995 691 citations Giovanni Scambia, Gabriella Ferrandina et al. International Journal of Cancer profile →
Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome

2016 276 citations Anna Fagotti, Gabriella Ferrandina et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gabriella Ferrandina Italy	63	5.7k	4.8k	4.6k	4.6k	3.4k	496	15.8k
William A. Cliby United States	64	6.8k 1.2×	3.5k 0.7×	3.8k 0.8×	5.2k 1.1×	4.2k 1.2×	288	14.3k
Pierluigi Benedetti Panici Italy	63	6.6k 1.2×	3.6k 0.7×	2.8k 0.6×	6.7k 1.4×	3.9k 1.1×	566	16.0k
David E. Cohn United States	58	4.3k 0.7×	2.9k 0.6×	2.9k 0.6×	5.0k 1.1×	2.0k 0.6×	377	12.2k
Deborah K. Armstrong United States	55	8.1k 1.4×	4.3k 0.9×	3.0k 0.6×	2.9k 0.6×	5.0k 1.4×	206	14.0k
Maurie Markman United States	63	7.9k 1.4×	6.4k 1.3×	4.3k 0.9×	2.7k 0.6×	6.6k 1.9×	417	19.9k
William P. McGuire United States	42	5.8k 1.0×	4.9k 1.0×	2.9k 0.6×	2.2k 0.5×	3.3k 1.0×	159	11.9k
Gordon C. Jayson United Kingdom	56	4.1k 0.7×	4.1k 0.8×	4.7k 1.0×	1.5k 0.3×	2.2k 0.6×	257	14.0k
Karen H. Lu United States	72	8.3k 1.5×	6.8k 1.4×	7.4k 1.6×	5.3k 1.1×	2.1k 0.6×	427	21.6k
Beth Y. Karlan United States	69	6.6k 1.2×	6.4k 1.3×	8.0k 1.7×	2.0k 0.4×	1.7k 0.5×	336	18.9k
Robert F. Ozols United States	63	5.1k 0.9×	5.4k 1.1×	5.5k 1.2×	1.4k 0.3×	3.3k 1.0×	205	14.5k

Countries citing papers authored by Gabriella Ferrandina

Since Specialization

Citations

This map shows the geographic impact of Gabriella Ferrandina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriella Ferrandina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriella Ferrandina more than expected).

Fields of papers citing papers by Gabriella Ferrandina

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabriella Ferrandina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriella Ferrandina. The network helps show where Gabriella Ferrandina may publish in the future.

Co-authorship network of co-authors of Gabriella Ferrandina

This figure shows the co-authorship network connecting the top 25 collaborators of Gabriella Ferrandina. A scholar is included among the top collaborators of Gabriella Ferrandina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabriella Ferrandina. Gabriella Ferrandina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fagotti, Anna, Chiara Cassani, Lorena Incorvaia, et al.. (2023). 42P Efficacy of maintenance with PARPi in advanced ovarian cancer according to the location of BRCA mutation. ESMO Open. 8(1). 100822–100822. 1 indexed citations

Bizzarri, Nicolò, Luca Russo, Miriam Dolciami, et al.. (2023). Radiomics systematic review in cervical cancer: gynecological oncologists’ perspective. International Journal of Gynecological Cancer. 33(10). 1522–1541. 14 indexed citations

Turco, Luigi Carlo, Diego Raimondo, Antonio Raffone, et al.. (2023). Horizontal versus vertical direction of posterior vaginal wall suture after eradication of rectovaginal endometriosis: A multicenter study. International Journal of Gynecology & Obstetrics. 164(2). 550–556. 1 indexed citations

Macchia, Gabriella, Maura Campitelli, Donatella Russo, et al.. (2023). MO-0049 SBRT in ovary cancer patients progressing within PARP-Inhibitor maintenance regimen:Epimetheo study. Radiotherapy and Oncology. 182. S16–S17. 2 indexed citations

Bizzarri, Nicolò, Camilla Nero, Francesca Ciccarone, et al.. (2021). Building a Personalized Medicine Infrastructure for Gynecological Oncology Patients in a High-Volume Hospital. Journal of Personalized Medicine. 12(1). 3–3. 4 indexed citations

Gallotta, Valerio, Soo Jeong, Carmine Conte, et al.. (2021). Minimally invasive surgical staging for early stage ovarian cancer: A long-term follow up. European Journal of Surgical Oncology. 47(7). 1698–1704. 28 indexed citations

Cruz, Ricardo Pedrini, et al.. (2020). Intestinal lymphangitis carcinomatosa related to ovarian cancer: Case report and review of the literature. Gynecologic Oncology Reports. 33. 100606–100606. 1 indexed citations

Bizzarri, Nicolò, Luigi Pedone Anchora, Paola Cattani, et al.. (2020). Peritoneal HPV‐DNA test in cervical cancer (PIONEER study): A proof of concept. International Journal of Cancer. 148(5). 1197–1207. 13 indexed citations

Mangili, Giorgia, Raffaella Cioffi, Saverio Danese, et al.. (2018). Does methotrexate (MTX) dosing in a 8-day MTX/FA regimen for the treatment of low-risk gestational trophoblastic neoplasia affect outcomes? The MITO-9 study. Gynecologic Oncology. 151(3). 449–452. 15 indexed citations

10.

Rosanò, Laura, Roberta Cianfrocca, Piera Tocci, et al.. (2014). Endothelin A Receptor/β-Arrestin Signaling to the Wnt Pathway Renders Ovarian Cancer Cells Resistant to Chemotherapy. Cancer Research. 74(24). 7453–7464. 87 indexed citations

11.

Gallotta, Valerio, Fabio Ghezzi, Enrico Vizza, et al.. (2014). Laparoscopic staging of apparent early stage ovarian cancer: Results of a large, retrospective, multi-institutional series. Gynecologic Oncology. 135(3). 428–434. 63 indexed citations

12.

Rosanò, Laura, Roberta Cianfrocca, Francesca Spinella, et al.. (2011). Acquisition of Chemoresistance and EMT Phenotype Is Linked with Activation of the Endothelin A Receptor Pathway in Ovarian Carcinoma Cells. Clinical Cancer Research. 17(8). 2350–2360. 164 indexed citations

13.

Raspaglio, Giuseppina, Flavia Filippetti, Enrica Martinelli, et al.. (2010). HuR Regulates β-Tubulin Isotype Expression in Ovarian Cancer. Cancer Research. 70(14). 5891–5900. 57 indexed citations

14.

Rutella, Sergio, Giuseppina Bonanno, Annabella Procoli, et al.. (2009). Cells with Characteristics of Cancer Stem/Progenitor Cells Express the CD133 Antigen in Human Endometrial Tumors. Clinical Cancer Research. 15(13). 4299–4311. 127 indexed citations

15.

Savelli, L., M. Ludovisi, E. Fruscella, et al.. (2008). Preoperative local staging of endometrial cancer: transvaginal sonography vs. magnetic resonance imaging. Ultrasound in Obstetrics and Gynecology. 31(5). 560–566. 140 indexed citations

16.

Battaglia, Alessandra, Alexia Buzzonetti, Giovanni Monego, et al.. (2007). Neuropilin‐1 expression identifies a subset of regulatory T cells in human lymph nodes that is modulated by preoperative chemoradiation therapy in cervical cancer. Immunology. 123(1). 129–138. 88 indexed citations

17.

Ferrandina, Gabriella, Franco O. Ranelletti, Valerio Gallotta, et al.. (2005). Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer. Gynecologic Oncology. 98(3). 383–389. 55 indexed citations

18.

Ferrandina, Gabriella, Franco O. Ranelletti, Libero Lauriola, et al.. (2002). Cyclooxygenase-2 (COX-2), Epidermal Growth Factor Receptor (EGFR), and Her-2/neu Expression in Ovarian Cancer. Gynecologic Oncology. 85(2). 305–310. 85 indexed citations

19.

Fattorossi, Andrea, Alessandra Battaglia, Luca Pierelli, et al.. (2001). Effects of granulocyte-colony-stimulating factor and granulocyte/macrophage-colony-stimulating factor administration on T cell proliferation and phagocyte cell-surface molecules during hematopoietic reconstitution after autologous peripheral blood progenitor cell transplantation. Cancer Immunology Immunotherapy. 49(12). 641–648. 18 indexed citations

20.

Scambia, Giovanni, Pierluigi Benedetti Panici, Gabriella Ferrandina, et al.. (1991). Cathepsin D and epidermal growth factor in human breast cyst fluid. British Journal of Cancer. 64(5). 965–967. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact